Wayne Macfadden MD, is Board Certified Psychiatrist with additional credentials in Addiction Medicine, who has over three decades of experience. Serving as the Global Medical Affairs Sleep Therapeutic Area Lead with Jazz Pharmaceuticals, Wayne Macfadden, MD, is also interested in medication-assisted treatment to address various conditions, such as alcohol use disorder.
Alcohol use disorder (AUD) remains а critical concern, impacting more than 29.5 million Americans, according to the National Survey on Drug Use and Health. The Food and Drug Administration has approved various medications to manage AUD. These medications work best with individuals who also are involved with therapy. Disulfiram is a tablet-based treatment prescribed to AUD patients undergoing detoxification and in the initial recovery phases. Its action entails creating unpleasant reactions, like headaches, nausea, and chest pain, upon consuming even small amounts of alcohol, thus making it successful in preventing relapse. Acamprosate is another drug that helps reduce alcohol cravings and increase abstinence rates for individuals undergoing alcohol detoxification. Although acamprosate does not prevent withdrawal symptoms after consuming alcohol, it can effectively complement comprehensive therapy. Another medication, naltrexone, effectively treats AUD by blocking the desirable effects of alcohol and enabling individuals to detach from its related pleasurable experiences. Naltrexone comes in tablet and injectable forms and is most effective alongside therapeutic interventions and a holistic treatment approach.
0 Comments
A renowned Psychiatrist who specializes in Addiction Psychiatry, Wayne Macfadden MD is the lead Psychiatrist at Spirit Lake Reservation in Fort Totten, North Dakota. As the first full-time Psychiatrist on the reservation, Wayne Macfadden MD established its only Suboxone® treatment clinic.
One of the clinic's function is to serve as a place for the treatment Substance Use Disorders using medication-assisted treatment (MAT), such as naltrexone for Alcohol Use Disorder. Before experiencing an Alcohol Use Disorder, patients pass through several stages. The first stage, known as the pre-alcoholic stage, starts when a person begins drinking as a social indulgence. In time, the urge to drink increases, and the individual's alcohol tolerance rises. At this point, the person may be using alcohol to reduce stress, relieve pain, or avoid worrying. In the second stage, called the early alcoholic stage, the individual may have experienced a black-out from excessive alcohol use. The person often is in denial and finds ways to consume alcohol secretly. At stage three, or the middle alcoholic stage, the individual begins to show visible signs by missing social obligations or work due to hangovers. Noticeable changes start to occur in the body, such as stomach bloating, weight gain or loss, facial redness, or sluggishness. Lastly, in the late alcoholic stage, the full effect of long-term drinking is evident. Severe health challenges associated with alcoholism, such as dementia and cirrhosis of the liver, may occur at this stage.
I published Schizophrenia as a Spectrum Disorder on Medium.
I published What Is Risperidone? on Medium.
I published Apathy — A Brief Overview on Medium.
I published How Substance Abuse Shapes the Brain’s Functionality on Medium.
I published Does Substance Abuse or Mental Illness Come First? on Medium.
I published COVID-19 affecting treatment of schizophrenia on Medium.
I published The Effectiveness of MAT in Treating Substance Use Disorders on Medium.
|
AuthorWayne Macfadden MD: Expert in both Clinical and Research Psychiatry. Archives
March 2024
Categories |